Featured patents

Anti-FMD Vaccine Composition and Preparation and Use Thereof
US 08551495 B2, Oct. 8, 2013, Yu Wang / Pharos Vaccine Inc. (Seongnam-Si, Gyeonggi-Do, KR)
A vaccine composition comprising a recombinant protein comprising from its…

Bacterial Toxin Vaccine
US 08846052 B2, Sept. 30, 2014, Kazuya Yoshida et al. / Idemitsu Kosan Co., Ltd. (Tokyo, JP)
A hybrid protein comprising:…

Chimeric Peptides Comprising HER-2 B-Cell Epitopes and T-Helper Epitopes
US 08470333 B2, June 25, 2013, Pravin Kaumaya / The Ohio State University Research Foundation (Columbus, US)
An immunogenic composition comprising a chimeric peptide, wherein the chimeric…

Class of Therapeutic Protein Based Molecules
US 08512710 B2, Aug. 20, 2013, Fang Fang et al. / Ansun Biopharma, Inc. (San Diego, US)
A fusion protein, comprising at least one catalytic domain of a sialidase…

Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
US 08815250 B2, Aug. 26, 2014, Daniel S. Rivera et al. / Biogen Idec Hemophilia Inc. (Waltham, US)
A method of treating a hemostatic disorder in a subject in need thereof…

Combined Human Papillomavirus VLP/gene Delivery System and Use Thereof as a Vaccine for Prophylaxis and Immunotherapy of Infectious Diseases and Tumors
US 08778351 B2, July 15, 2014, Young-Eun Ellen Lee et al. / University of Rochester (Rochester, US)
A method of inducing an immune response against a pathogen comprising:…

Compositions for Immunotherapy and Uses Thereof
US 08771701 B2, July 8, 2014, Geoffrey A. Pietersz et al. / MacFarlane Burnet Institute for Medical Research and Public Health Ltd (Melbourne, AU)
A method of eliciting a cytotoxic T lymphocyte response in an human to an antigen…

FGFR2-IIIb Fusion Proteins and Methods of Making Them
US 08501191 B2, Aug. 6, 2013, Diane Hollenbaugh et al. / Five Prime Therapeutics, Inc. (San Francisco, US)
An FGFR2 fusion protein comprising a polypeptide and a fusion partner,…

Fusion Protein With HIV Antigen
US 08518410 B2, Aug. 27, 2013, Jacques F. Banchereau et al. / Baylor Research Institute (Dallas, US)
A fusion protein comprising the formula:…

Fusion Proteins and Related Compositions, Methods and Systems for Treatment And/Or Prevention of Atherosclerosis
US 08506964 B2, Aug. 13, 2013, Jan Holmgren et al. / CardioVax, LLC (Torrance, US)
A fusion protein comprising…

Genetic Constructs and Compositions Comprising RRE and CTE and Uses Thereof
US 08685407 B2, April 1, 2014, Karuppiah Muthumani et al. / The Trustees of the University of Pennsylvania (Philadelphia, US)
A genetic construct that comprises:…

Group a Streptococcus Multivalent Vaccine
US 08697085 B2, April 15, 2014, James B. Dale / University of Tennessee Research Foundation (Knoxville, US)
An immunogenic composition comprising at least 31 immunogenic peptides, wherein…

HER-2/neu Fusion Proteins
US 08568733 B2, Oct. 29, 2013, Dirk Gheysen et al. / GlaxoSmithKline Biologicals SA (Rixensart, BE)
An isolated polypeptide consisting of SEQ ID…

Hybrid Prokaryotic-Eukaryotic Tubulins and Use Thereof
US 08741307 B2, June 3, 2014, F. Jon Kull et al. / Trustees of Dartmouth College (Hanover, US)
An isolated hybrid Prosthecobacter -eukaryotic tubulin A protein comprising…

Identification, Optimization and Use of Cryptic HLA-B7 Epitopes for Immunotherapy
US 08465747 B2, June 18, 2013, Jeanne Menez-Jamet et al. / Vaxon Biotech (Evry Cedex, FR)
A cryptic HLA-B*0702-restricted epitope consisting of APRSPLAPS (SEQ ID NO:…

Immunogenic Compositions Comprising Mycobacterium Tuberculosis Polypeptides and Fusions Thereof
US 08486414 B2, July 16, 2013, Rhea N. Coler et al. / Infectious Disease Research Institute (Seattle, US)
A composition comprising an immunostimulant and a combination of two or more…

Immunological Herpes Simplex Virus Antigens and Methods for Use Thereof
US 08852602 B2, Oct. 7, 2014, David M. Koelle et al.
A pharmaceutical composition comprising an isolated herpes simplex virus type 2…

Inhibition of Secretion From Non-Neuronal Cells
US 08852603 B2, Oct. 7, 2014, Keith Alan Foster et al. / Syntaxin Limited (Abingdon, Oxfordshire, GB)
A method of suppressing hypersecretion from an inflammatory cell in a patient…

Joint-Homing Peptides and Uses Thereof
US 08623377 B2, Jan. 7, 2014, Kamal Moudgil et al. / University of Maryland, Baltimore (Baltimore, US)
A peptide that homes to a joint of an animal, comprising a sequence CRNADKFPC…

Kidney Specific Tumor Vaccine Directed Against Kidney Tumor Antigen G-250
US 08741306 B2, June 3, 2014, Arie Belldegrun et al. / The Regents of the University of California (Oakland, US)
A method of inducing an immune response against a G250 kidney-specific antigen…

Method for Generating Immune Responses Utilizing Nucleic Acids Encoding Fusion Proteins Comprising CD4 Minimal Modules and Invasin Polypeptides That Are Capable of Binding to the HIV Envelope and Exposing Cryptic Neutralization Epitopes
US 08568734 B2, Oct. 29, 2013, Indresh K. Srivastava et al. / Novartis Vaccines and Diagnostics Inc. (Emeryville, US)
A method of generating an immune response, the method comprising…

Method of Generating an Immune Response in a Subject Using Fusion Proteins Comprising CD4 Minimal Modules and HIV Tat Scaffold Polypeptides That Are Capable of Binding to the HIV Envelope and Exposing Cryptic Neutralization Epitopes
US 08637044 B2, Jan. 28, 2014, Rino Rappuoli et al. / Novartis AG (Basel, CH)
A method of generating an immune response in a subject, the method comprising:…

Method of Inducing an Antiviral Immune Response Against HIV-1 Utilizing Chimeric HIV Env Proteins Comprising CD4 Mini-Proteins or CD4 Mimetics
US 08470334 B2, June 25, 2013, Susan W. Barnett et al. / Novartis Vaccines & Diagnostics, Inc (Emeryville, US)
A method of inducing an immune response in a subject, comprising:…

Methods of Immune Modulation With Death Receptor-Induced Apoptosis
US 08551494 B2, Oct. 8, 2013, Haval Shirwan / University of Louisville Research Foundation, Inc. (Louisville, US)
A method for inducing apoptosis in an activated lymphocyte, comprising exposing…

Multiepitope Vaccine for Her2/Neu-associated Cancers
US 08852604 B2, Oct. 7, 2014, Andreas Kammer et al. / Pevion Biotech AG (Ittigen, CH)
A fusion peptide comprising three non-contiguous B cell epitopes…

Non-Hemolytic LLO Fusion Proteins and Methods of Utilizing Same
US 08771702 B2, July 8, 2014, Yvonne Paterson et al. / The Trustees of the University of Pennsylvania (Philadelphia, US)
A recombinant protein comprising a listeriolysin O (LLO) protein comprising…

Polyvalent Chimeric OspC Vaccinogen and Diagnostic Antigen
US 08778352 B2, July 15, 2014, Christopher Earnhart et al. / Virginia Commonwealth University (Richmond, US)
A chimeric recombinant protein comprising…

Prenatal Enzyme Replacement Therapy for Hypophosphatasia
US 08784833 B2, July 22, 2014, Adriana Maria Monta{umlaut over (n)}o Suarez et al. / Saint Louis University (St. Louis, US)
A method for treating hypophosphatasia in a fetus or embryo comprising the step…

Recombinant Avian Infectious Coryza Vaccine and Process for Preparing Same
US 08647634 B2, Feb. 11, 2014, Susumu Baba et al. / The Chemo-Sero-Therapeutic Research Institute (Kumamoto-shi, JP)
A process for preparing a recombinant avian infectious coryza vaccine,…

Recombinant F1-V Plague Vaccine
US 08647633 B2, Feb. 11, 2014, David G. Heath et al. / The United States of America as Represented by the Secretary of the Army (Washington, US)
A composition comprising a purified fusion protein comprising all of F1 antigen…

Patentorg has 42 documents under Fusion Protein or Fusion Polypeptide Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot